{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:12:03Z","timestamp":1786986723884,"version":"build-2736575974"},"reference-count":27,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi Aventis R&D","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.chest.2018.08.1083","type":"journal-article","created":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T04:14:09Z","timestamp":1543983249000},"page":"1359-1370","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["Idiopathic Pulmonary Fibrosis"],"prefix":"10.1016","volume":"154","author":[{"given":"Ganesh","family":"Raghu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Richeldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Jagerschmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Subramaniam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Laure","family":"Ozoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne A.","family":"Esperet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Soubrane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.chest.2018.08.1083_bib1","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","article-title":"An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management","volume":"183","author":"Raghu","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.chest.2018.08.1083_bib2","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1164\/rccm.201006-0894CI","article-title":"Clinical course and prediction of survival in idiopathic pulmonary fibrosis","volume":"183","author":"Ley","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.chest.2018.08.1083_bib3","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1164\/rccm.201506-1063ST","article-title":"An official ATS\/ERS\/JRS\/ALAT clinical practice guideline: treatment of idiopathic pulmonary fibrosis. An update of the 2011 clinical practice guideline","volume":"192","author":"Raghu","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"13","key":"10.1016\/j.chest.2018.08.1083_bib4","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMp1500526","article-title":"Forced vital capacity in idiopathic pulmonary fibrosis--FDA review of pirfenidone and nintedanib","volume":"372","author":"Karimi-Shah","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"9779","key":"10.1016\/j.chest.2018.08.1083_bib5","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/S0140-6736(11)60405-4","article-title":"Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials","volume":"377","author":"Noble","year":"2011","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.chest.2018.08.1083_bib6","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis","volume":"370","author":"Richeldi","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.chest.2018.08.1083_bib7","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1164\/rccm.201403-0509PP","article-title":"New therapeutic targets in idiopathic pulmonary fibrosis. Aiming to rein in runaway wound-healing responses","volume":"190","author":"Ahluwalia","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.chest.2018.08.1083_bib8","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3109\/01902148.2010.538132","article-title":"Differential expression of monocyte\/macrophage- selective markers in human idiopathic pulmonary fibrosis","volume":"37","author":"Desai","year":"2011","journal-title":"Exp Lung Res"},{"key":"10.1016\/j.chest.2018.08.1083_bib9","doi-asserted-by":"crossref","first-page":"4759040","DOI":"10.1155\/2016\/4759040","article-title":"Comparative study of circulating MMP-7, CCL18, KL-6, SP-A, and SP-D as disease markers of idiopathic pulmonary fibrosis","volume":"2016","author":"Hamai","year":"2016","journal-title":"Dis Markers"},{"issue":"1","key":"10.1016\/j.chest.2018.08.1083_bib10","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1164\/rccm.201101-0058OC","article-title":"Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis","volume":"185","author":"Richards","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.chest.2018.08.1083_bib11","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.trsl.2012.01.012","article-title":"Peripheral blood biomarkers in idiopathic pulmonary fibrosis","volume":"159","author":"Vij","year":"2012","journal-title":"Transl Res"},{"issue":"16","key":"10.1016\/j.chest.2018.08.1083_bib12","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJMc1013504","article-title":"A\u00a0variant in the promoter of MUC5B and idiopathic pulmonary fibrosis","volume":"364","author":"Zhang","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.chest.2018.08.1083_bib13","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1164\/rccm.200703-463PP","article-title":"Acute exacerbations of idiopathic pulmonary fibrosis","volume":"176","author":"Collard","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.chest.2018.08.1083_bib14","first-page":"185","article-title":"Standardized single breath normal values for carbon monoxide diffusing capacity","volume":"123","author":"Crapo","year":"1981","journal-title":"Am Rev Respir Dis"},{"issue":"8","key":"10.1016\/j.chest.2018.08.1083_bib15","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1164\/rccm.200808-1201OC","article-title":"Serum CC-chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosis","volume":"179","author":"Prasse","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.chest.2018.08.1083_bib16","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J\u00a0R Stat Soc Series B Stat Methodol"},{"issue":"1","key":"10.1016\/j.chest.2018.08.1083_bib17","first-page":"1","article-title":"Regularization paths for generalized linear models via coordinate descent","volume":"33","author":"Friedman","year":"2010","journal-title":"J\u00a0Stat Softw"},{"issue":"4","key":"10.1016\/j.chest.2018.08.1083_bib18","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/j.1365-2656.2008.01390.x","article-title":"A\u00a0working guide to boosted regression trees","volume":"77","author":"Elith","year":"2008","journal-title":"J\u00a0Anim Ecol"},{"issue":"10","key":"10.1016\/j.chest.2018.08.1083_bib19","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1164\/rccm.201701-0254OC","article-title":"Serum matrix metalloproteinase-7, respiratory symptoms, and mortality in community-dwelling adults. MESA (Multi-Ethnic Study of Atherosclerosis)","volume":"196","author":"Armstrong","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.chest.2018.08.1083_bib20","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nm.2989","article-title":"Identification of human epididymis protein-4 as a fibroblast-derived mediator of fibrosis","volume":"19","author":"LeBleu","year":"2013","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.chest.2018.08.1083_bib21","doi-asserted-by":"crossref","first-page":"L932","DOI":"10.1152\/ajplung.00437.2007","article-title":"Prostasin expression is regulated by airway surface liquid volume and is increased in cystic fibrosis","volume":"294","author":"Myerburg","year":"2008","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"2","key":"10.1016\/j.chest.2018.08.1083_bib22","doi-asserted-by":"crossref","first-page":"L97","DOI":"10.1152\/ajplung.00303.2011","article-title":"Activity and inhibition of prostasin and matriptase on apical and basolateral surfaces of human airway epithelial cells","volume":"303","author":"Nimishakavi","year":"2012","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"5","key":"10.1016\/j.chest.2018.08.1083_bib23","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/art.22559","article-title":"CCL18 as an indicator of pulmonary fibrotic activity in idiopathic interstitial pneumonias and systemic sclerosis","volume":"56","author":"Prasse","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.chest.2018.08.1083_bib24","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1080\/01902140802271826","article-title":"The time course of expression of genes involved in specific pathways in normal human bronchial epithelial cells following exposure to cigarette smoke","volume":"34","author":"Parsanejad","year":"2008","journal-title":"Exp Lung Res"},{"issue":"6","key":"10.1016\/j.chest.2018.08.1083_bib25","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S2213-2600(15)00048-X","article-title":"Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study","volume":"3","author":"Jenkins","year":"2015","journal-title":"Lancet Respir Med"},{"issue":"7","key":"10.1016\/j.chest.2018.08.1083_bib26","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1164\/ajrccm.164.7.2003140","article-title":"Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model","volume":"164","author":"King","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.chest.2018.08.1083_bib27","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.21037\/jtd.2016.03.89","article-title":"Clinical characteristics of idiopathic pulmonary fibrosis patients according to their smoking status","volume":"8","author":"Kishaba","year":"2016","journal-title":"J\u00a0Thorac Dis"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369218324917?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369218324917?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T22:57:37Z","timestamp":1762124257000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369218324917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S0012369218324917"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2018.08.1083","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Idiopathic Pulmonary Fibrosis","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2018.08.1083","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc under license from the American College of Chest Physicians.","name":"copyright","label":"Copyright"}]}}